 Connection
Peter Anderson to Antitubercular Agents
This is a "connection" page, showing publications Peter Anderson has written about Antitubercular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.450 |
|
|
|
-
Nerguizian D, Klein B, Abdelmawla F, Gomez J, Anderson PL, Bushman L, Brooks KM. Validation of an UHPLC-MS/MS Assay for the Quantification of Isoniazid and Four Major Metabolites in Human Plasma. Biomed Chromatogr. 2026 Sep; 40(9):e70550.
Score: 0.210
-
Mpofu R, Chandiwana N, Sokhela S, Moorhouse M, Venter F, Anderson PL, Wiesner L, Boffito M, Maartens G, Sinxadi P. The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis. J Acquir Immune Defic Syndr. 2026 Apr 01; 101(4):424-431.
Score: 0.204
-
Martiniano SL, Wagner BD, Brennan L, Wempe MF, Anderson PL, Daley CL, Anthony M, Nick JA, Sagel SD. Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis. J Cyst Fibros. 2021 09; 20(5):772-778.
Score: 0.036
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|